Evidence map›Paper›PMID 36873891›Full record

ArticleFrontiers in medicine2023

Adiponectin/leptin ratio as a predictor of acute rejection in early post-transplant period in patients after kidney transplantation.

Karol Graňák, Matej Vnučák, Monika Beliančinová, Patrícia Kleinová, Margaréta Pytliaková, Marián Mokáň, Ivana Dedinská

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Karol GraňákTransplant Centre, University Hospital Martin, Martin, Slovakia.
Matej VnučákTransplant Centre, University Hospital Martin, Martin, Slovakia.
Monika BeliančinováTransplant Centre, University Hospital Martin, Martin, Slovakia.
Patrícia KleinováTransplant Centre, University Hospital Martin, Martin, Slovakia.
Margaréta PytliakováDepartment of Gastrointestinal Internal Medicine, University Hospital Martin, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia.
Marián MokáňDepartment of Internal Medicine, University Hospital in Martin, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia.
Ivana DedinskáTransplant Centre, University Hospital Martin, Martin, Slovakia.
Comenius University Bratislava · SKMartin University Hospital · SK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Adipokines are largely involved in the regulation of immune system activity. While leptin is the main pro-inflammatory marker of adipose tissue, adiponectin is characterized by anti-inflammatory effects. The aim of our study was to determine the risk of acute graft rejection in protocol biopsy depending on the adiponectin/leptin (A/L) ratio in patients after kidney transplantation (KT). Materials and methods: A total of 104 patients were included in the prospective analysis, in whom the levels of adipokines were examined pre-transplant, in the 3rd month after KT and the A/L ratio was calculated. In the 3rd month after KT, all patients underwent protocol biopsy of the graft and examination of donor-specific antibodies (DSA) using the Luminex method. Results: After adjusting for differences in the basic characteristics of the donor and recipient, we identified a subgroup with A/L ratio < 0.5 pre-transplant [HR 1.6126, ( Conclusion: This is the first study to investigate the relationship between A/L ratio and immunological risk in terms of the development of rejection changes in patients after KT. In our study, we found that A/L ratio < 0.5 is an independent risk factor for the development of acute humoral rejection and

Indexed as

acute rejectionadiponectin/leptin ratioadipose tissue hormonesantibody-mediated rejectionkidney transplantation

Identifiers

PMID36873891
PMCPMC9981627
OpenAlexW4321239515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.